Study guide
4.4 Recordkeeping, Retention & Documentation
PTCB Supply Chain and Inventory Management Certificate Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
Exam Facts & Logistics Eligibility & the CPhT-Adv Pathway How to Use This Guide & Study Plan
2 Chapter 2: FDA, DEA, and State Regulatory Framework
2.1 FDA Role, Jurisdiction & Drug Approval 2.2 FDA Registration & Trading-Partner Reporting 2.3 DEA Schedules & Registration 2.4 State Boards of Pharmacy & Entity Licensure
3 Chapter 3: DSCSA — Track, Trace & Transaction Data
3.1 DSCSA Scope, Products & Exceptions 3.2 Serialization, the Product Identifier & EDDS 3.3 T3 Transaction Data — TI, TH & TS 3.4 Suspect & Illegitimate Product Handling
4 Chapter 4: 340B, Hazardous Drugs, Recalls & Recordkeeping
4.1 340B Drug Pricing Program & HRSA 4.2 USP <800> & NIOSH Hazardous Drug Handling 4.3 FDA Recall Classifications & Management 4.4 Recordkeeping, Retention & Documentation
5 Chapter 5: Inventory Methods & Stock Rotation
5.1 Inventory Systems Overview 5.2 Stock Rotation, FEFO & Expiration Management 5.3 ABC Analysis, Min-Max, Par & Reorder Points 5.4 JIT, Kanban, Two-Bin & Seasonal/Emergency Forecasting
6 Chapter 6: Inventory KPIs & Math
6.1 Inventory Turnover & Days on Hand 6.2 Fill Rate, Carrying Cost & Stockout Cost 6.3 Par-Level & Reorder Calculations
7 Chapter 7: Documentation, CS Records & Automation
7.1 Documentation & File Maintenance 7.2 Controlled-Substance Records & Reporting 7.3 Automation: ADCs, Carousels & Barcoding 7.4 Cold Chain & Temperature Management
8 Chapter 8: Shortages, Contracts & Returns
8.1 Drug Shortage Mitigation & Pricing Implications 8.2 Contract Types & Compliance 8.3 Returns & Reverse Distribution
9 Chapter 9: Manufacturers, Wholesalers & 3PLs
9.1 Manufacturers (Rx & OTC) & Virtual Manufacturers 9.2 Primary Wholesale Distributors 9.3 Secondary, Specialty & OTC-Only Distributors; Virtual Wholesalers 9.4 Repackagers/Relabelers & Third-Party Logistics (3PLs)
10 Chapter 10: Compounders, Specialty & Alternative Suppliers
10.1 503A Compounding Pharmacies 10.2 503B Outsourcing Facilities 10.3 Specialty Pharmacy & Limited-Distribution Drugs 10.4 Biosimilars/Biologics, Pharmacy-to-Pharmacy Transfers & Foreign Sourcing
11 Chapter 11: Pricing, GPOs, PBMs & Health Systems
11.1 Pricing Mechanics 11.2 GPOs, IDNs & Health Systems 11.3 PBMs & ADRs
4.4 Recordkeeping, Retention & Documentation
Key Takeaways Explain This Topic AI
DSCSA requires trading partners to retain transaction information and transaction statements for at least 6 years; transaction history stopped being required on November 27, 2023.
DEA requires controlled-substance records (inventories, order forms, dispensing, wastage) to be retained for at least 2 years and readily retrievable.
State boards of pharmacy set dispensing record retention (often 5+ years); when federal and state requirements differ, the longer, more stringent period governs.
340B records (purchase, dispensing, split-billing, child site, duplicate-discount compliance) must be maintained and are auditable by HRSA.
Good documentation practices require every entry to be dated, signed (or identified by a unique electronic identifier), permanent, contemporaneous, legible, and attributable.
Last updated: September 2026
Recordkeeping and Retention
Pharmacy supply-chain operations generate records that must be retained for specific periods under federal and state law. Good recordkeeping supports recalls, audits, and investigations, and is a core Domain 2 (Inventory Management, Documentation, and Recordkeeping) competency.
Federal Retention Requirements
Record Type Retention Period Authority
DSCSA transaction records (Transaction Information and Transaction Statement today; Transaction History for records predating its November 27, 2023 sunset; EDDS) 6 years DSCSA Title II / FDA
DEA controlled-substance records (inventories, order forms/222, dispensing, receipts) 2 years DEA (21 CFR)
State pharmacy dispensing records (prescriptions, dispensing logs) Varies — often 5+ years State board of pharmacy
- Invoices and receipts Per state law (often 5+ years); align with DSCSA 6-year for traceability State / DSCSA
- Wastage logs (controlled substances) 2 years (DEA); often longer by state DEA / state
- Recall records Per facility policy; retained with the quality file for audit and trending FDA / facility
Hazardous drug handling records (spills, exposure, disposal) Per USP <800>, facility, and EPA requirements USP / EPA / facility
- 340B program records Per HRSA program requirements; auditable HRSA
- DSCSA: 6 Years
Under DSCSA Title II , trading partners must keep transaction information and transaction statement for not less than 6 years . Transaction history (TH) was part of this trio until section 582(k)(1) ended the requirement to provide or receive it on November 27, 2023 ; any TH records created before that date must still be retained for their own 6-year window, but new transactions no longer generate a TH document. This retention rule supports track-and-trace investigations and the enhanced drug distribution security (EDDS) requirements, whose compliance dates were phased in from May 27, 2025 (manufacturers and repackagers) through November 27, 2027 (small dispensers). If a suspect or illegitimate product is identified, these records let the supply chain trace the product back to the manufacturer.
DEA: 2 Years
DEA registrants must maintain controlled-substance records for at least 2 years and keep them readily retrievable. This includes initial and biennial inventories, DEA Form 222 order forms, dispensing records, and wastage documentation. Many states require longer retention (5 years or more), so the stricter state requirement governs.
State Dispensing Records
State boards of pharmacy set retention for prescription and dispensing records — commonly 5 years , sometimes longer for controlled substances or pediatric records. Pharmacy technicians should know their state's requirement; when federal and state differ, the longer period applies.
Invoices, Wastage, and Recall Records
Invoices and receipts document receipt of drug inventory and support DSCSA traceability — retain at least as long as the DSCSA window (6 years) where they serve as transaction records.
Wastage logs document the destruction of expired, damaged, or partially administered drugs — especially controlled substances, which require a witness signature and often a specific form.
Recall records document the recall notice, quantity quarantined, return/destruction, and notifications; keep these as part of the quality file for audit and trending.
340B Audit Records
HRSA may audit covered entities and review several years of 340B records. Maintain 340B purchase records, dispensing records tied to eligible patients, split-billing software output, child site records, and duplicate-discount compliance documentation. Accurate, retrievable records are the entity's defense in an audit; missing records can result in repayment demands.
Good Documentation Practices (GDP)
All records should follow good documentation practices :
- Date every entry (and time where relevant, e.g., controlled-substance administration and wastage)
- Signature (or unique electronic identifier) of the person making the entry
Permanence — entries in ink or an audit-trailed electronic system; no pencil, no correction fluid; errors corrected with a single line, initialed and dated, with the correct entry alongside
- Contemporaneous — recorded at the time of the event, not reconstructed later
- Legible and attributable — traceable to the specific person and event
- Worked Scenario: A DSCSA Audit
A wholesaler request reaches a pharmacy for transaction documents on a drug purchased 4 years ago that is now under investigation. The pharmacy must be able to retrieve, within a reasonable time, the transaction information and transaction statement for that sale (plus any transaction history document that predates the November 2023 sunset, if one exists for that purchase). If records were kept only 3 years, the pharmacy would be unable to comply — a DSCSA violation. A 6-year retention policy and retrievable storage (electronic or paper) are essential.
Electronic vs. Paper Records
Records may be paper or electronic, but electronic systems must have an audit trail that captures who made each entry, when, and any changes. The system must be validated, access-controlled, and backed up. Paper records must be legible, indelible, and stored to prevent loss or damage. Either format is acceptable as long as the records are retrievable for the full retention period.
"Readily Retrievable" for DEA
DEA requires controlled-substance records to be readily retrievable — the registrant must be able to produce them on request, separated by drug schedule, within a reasonable time. Filing systems that bury CS records among general pharmacy files, or that require extensive searching, do not meet this standard. Many pharmacies maintain a separate, indexed CS file (paper or electronic) specifically to satisfy retrievability.
Audit-Readiness
Audit-readiness means any record can be produced quickly: a DSCSA T3 pull for a suspect product, a DEA inspection request, a state board audit, or an HRSA 340B audit. The combination of correct retention periods, retrievable storage, and good documentation practices turns recordkeeping from a chore into a compliance asset.